Today at 12:55pm
Arlington’s pickleball players, eager to see the sport grow, will soon have more courts to play on.
The YMCA Arlington Tennis & Squash Center, at 3400 13th Street N. in the Virginia Square area, is repainting three tennis courts to make room for six pickleball courts. This change is part of an effort to meet the growing demand for facilities as the sport gains popularity.
“In the D.C. region, pickleball is exploding,” said Carlo Impeduglia, Associate Director of Racquets at the Y in Arlington.
He attributes the local and nationwide surge in interest in pickleball and other racquet sports to people searching for social sports where players can stay distanced during the pandemic.
Broomfield, Colorado (PRWEB) June 01, 2021 Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that the company
Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment
Laboratory Developed Test for Manual and Image Analysis-assisted Pathologist Interpretation
News provided by
Share this article
Share this article
WESTMINSTER, Colo. and CAMBRIDGE, Mass., April 12, 2021 /PRNewswire/ Flagship Biosciences, the leader in data-centric pathology and tissue analysis, and Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced a partnership to use a clinically validated tumor expression assay utilizing RNAscope
® and tissue image analysis. In a poster shared this week at the American Association for Cancer Research (AACR) Annual Meeting 2021, the companies presented data on the validation of a Dickkopf-1 (DKK1) RNAscope chromogenic in situ hybridization (CISH) assay and digital image analysis solution.
Flagship Biosciences Announces Strategic Executive Team Additions prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Flagship Biosciences Announces Patent
Share Article
Patent Number 10,839,512 Issued for New Flagship Biosciences Tissue Sample Image Dot Detection Method
“We are pleased to announce this new patent for CISH and FISH dot detection,” said Trevor Johnson, Flagship’s CEO. “Our internal experiments show that our new method can identify and separate dots, especially if they are very close together, better than any previous method. WESTMINSTER, Colo. (PRWEB) February 17, 2021 Flagship Biosciences, the leader in data-centric pathology tissue analysis, today announced that the United States Patent and Trademark Office has issued Flagship a new patent, number 10,839,512 entitled “Method of dot detection within images of tissue samples.” The patent, one of several recent patents issued to Flagship, discloses a method to identify CISH (chromogenic in situ hybridization) and FISH (fluorescence in situ hybridizat